• Molecular NameRufinamide
  • SynonymNA
  • Weight238.197
  • Drugbank_IDDB06201
  • ACS_NO106308-44-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.24
  • pkaN/A
  • LogD (pH=7, predicted)0.24
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.22
  • LogSw (predicted, AB/LogsW2.0)1.42
  • Sw (mg/ml) (predicted, ACD/Labs)1.44
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds3
  • TPSA73.8
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability85.0
  • Protein binding34.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A